The predominate means by which cancer cells resist Paclitaxel exposure is via up-regulation of the transmembrane transport protein ATP binding cassette B1 (ABCB1), also known as P-glycoprotein 1 (P-gp) [29]. The gene discussed is ABCB1; the disease is cancer.